• Founded
  • 2015

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

BIOSQUAL General Information


Developer of analogues of squalamine based in France. The company develops a series of analogues of squalamine and pharmaceutical formulations for clinical use.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 10, rue Clapier
  • 13001 Marseille
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIOSQUAL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 17-Feb-2022 00000 Completed Out of Business
2. Angel (individual) 05-Nov-2018 00000 00000 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view BIOSQUAL’s complete valuation and funding history, request access »


Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 000.000000 0000.00 0000.00 00 0000.00 000
To view BIOSQUAL’s complete cap table history, request access »


BIOSQUAL Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3092490-A1 Squalamine-like aminosteroid compound for use in the treatment and / or prevention of dermatophytosis Inactive 08-Feb-2019 0000000000 0
FR-3092492-A1 Cosmetic use of an aminosteroid compound analogous to squalamine to reduce or prevent bad skin odor Inactive 08-Feb-2019 00000000 0